title: JAK2 V617F mutation in leukaemic transformation of philadelphia-negative chronic myeloproliferative disorders.
authors.forename: Davide
authors.initials: D
authors.lastname: Rossi
authors.forename: Clara
authors.initials: C
authors.lastname: Deambrogi
authors.forename: Daniela
authors.initials: D
authors.lastname: Capello
authors.forename: Michaela
authors.initials: M
authors.lastname: Cerri
authors.forename: Monia
authors.initials: M
authors.lastname: Lunghi
authors.forename: Guido
authors.initials: G
authors.lastname: Parvis
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Saglio
authors.forename: Gianluca
authors.initials: G
authors.lastname: Gaidano
authors.forename: Daniela
authors.initials: D
authors.lastname: Cilloni
mesh_terms: D000208:Acute Disease; D000328:Adult; D000368:Aged; D002471:Cell Transformation, Neoplastic / Q000235:genetics; D005260:Female; D006801:Humans; D053614:Janus Kinase 2; D007951:Leukemia, Myeloid / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000235:genetics*; D010677:Philadelphia Chromosome; D011505:Protein-Tyrosine Kinases / Q000235:genetics*; D011518:Proto-Oncogene Proteins / Q000235:genetics*
chemical_list: D011518:Proto-Oncogene Proteins; D011505:Protein-Tyrosine Kinases; C507924:JAK2 protein, human; D053614:Janus Kinase 2